• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Markets

Strength in Growth Names Is Giving the Market a More Upbeat Feel

Apple in particular is helping the bullish cause.
By JAMES "REV SHARK" DEPORRE
Aug 09, 2018 | 02:06 PM EDT
Stocks quotes in this article: AAPL, HTGM, AMRS, SRPT, SGMO, GBT

The indices remain close to flat but breadth is the inverse of yesterday with about 4 gainers to every 3 losers. There is better momentum action in the Nasdaq names today and Apple ( AAPL) in particular is helping the bullish cause. Broader strength in growth names is what is giving the market a more upbeat feel. It is still rather choppy but the action in individual stocks is a bit more consistent although still sedate due to the summer doldrums.
 
I am not finding many new buys but I am identifying stocks that I feel will offer good opportunities into the next set of quarterly reports which will start in October. We have to deal with the weakest time of the year in the interim so may inclination will be to look to average in on weakness.
 
Yesterday I mentioned two small caps that I think are on the cusp of being discovered. They are HTG Molecular ( HTGM) and Amyris ( AMRS) .
 
Today I have three biotechnology names that I'm watching for opportunities to add to further.
 
The first is Sarepta Therapeutics ( SRPT) which announced earnings today and is trading sharply higher on a very upbeat report. The stock has been drifting lower after significant positive news hit in June and it had a manufacturing issue that pushed it down at the end of July. It looks to be regaining its technical footing and I will be watching for additional entries.
 
The second name I'm watching is Sangamo ( SGMO) the stock had earnings today as well as some clinical results that are receiving a positive spin. There has been much chaos in the "gene editing" space and that has unfairly impacted SGMO according to its supporters. The stock has a strong 'cult following' which is a source of criticism among the mainstream biotech community but it has the potential for substantial momentum if it can break the downtrend that started back in March.
 
The third name is Global Blood Therapeutics ( GBT) . GBT has potential for accelerated approval of its sickle cell disease in the near term and is developing nicely. This is a potential billon dollar drug in a market, so the upside is substantial.
 
 
 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev Shark was long HTGM, AMRS, SRPT, SGMO and GBT.

Jim Cramer and the AAP team hold a position in Apple for their Action Alerts PLUS Charitable Trust Portfolio . Want to be alerted before Cramer buys or sells AAPL? Learn more now .
 
TAGS: Investing | U.S. Equity | Markets | Stocks

More from Markets

Doug Kass: We May Now Be Approaching Another Important Top in the Market

Doug Kass
Aug 16, 2022 1:30 PM EDT

To justify buying at today's prices means that one expects a new Bull Market leg - something I remain dubious of.

This Market Needs Some Corrective Action

James "Rev Shark" DePorre
Aug 16, 2022 11:18 AM EDT

It's likely to occur on a rolling basis and won't be that evident in the senior indexes.

Markets, Awful Empire State Index, Economy, Inflation, Covid Booster, Disney

Stephen Guilfoyle
Aug 16, 2022 7:27 AM EDT

The report from New York is certainly consistent with what one would expect to see as an economy heads either into recession or more deeply into recession.

A Collision Is About to Occur

Bob Lang
Aug 15, 2022 12:45 PM EDT

When will this bear market end?

The Aggressive Chasing Has Cooled Off

James "Rev Shark" DePorre
Aug 15, 2022 11:58 AM EDT

Is this a healthy pause that will set up the next leg higher or a stalling action that will produce a rollover?

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 02:23 PM EDT STEPHEN GUILFOYLE

    We're Cleaning Out This Retailer From the Bullpen

    Check out the latest moves in TheStreet's Stocks U...
  • 10:24 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    To Improve Your Trading and Investing, Spend More ...
  • 08:44 AM EDT PETER TCHIR

    CPI Beats Expectations, But Maybe Not the 'Whisper'?

    Slightly better-than-expected inflation across the...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login